Core Viewpoint - The article discusses the implementation of a special HPV vaccine policy in Shenyang's Tiexi District, aimed at promoting public health and preventing HPV-related diseases among both males and females, reflecting a shift towards a more inclusive approach to HPV prevention [1][2]. Group 1: HPV Vaccine Policy - The policy covers females aged 9-45 and males aged 9-26, establishing a comprehensive HPV prevention network that includes targeted protection for youth and ongoing coverage for adult women [1] - Eligible individuals can receive free doses of the HPV vaccine: for the imported quadrivalent vaccine, females aged 9-13 receive the second dose for free, while females aged 14-26, 35-45, and males aged 9-26 receive the third dose for free [1] - The imported nine-valent HPV vaccine offers similar benefits, with free second doses for females aged 9-14 and free third doses for females aged 15-26, 35-45, and males aged 16-26 [1] Group 2: Public Health Impact - The initiative aims to block the HPV transmission chain and reduce the risk of related diseases such as anal and penile cancers in males, marking a transition from a single-gender cervical cancer prevention strategy to a more comprehensive approach [2] - The nine-valent HPV vaccine is the first and only approved vaccine in China that can prevent cancers and diseases caused by persistent HPV infections in both males and females [2] Group 3: Participation and Timeline - The program is open to all eligible individuals regardless of residency, encouraging widespread participation in the health initiative [2] - The vaccination campaign has a time window, with the first dose discount available until November 30, 2025, and individuals must complete their vaccination by May 31, 2026, to benefit from the discounts [2]
沈阳推进HPV疫苗接种惠民活动 加速构建男女共防免疫屏障
Xin Hua Wang·2025-08-22 01:08